Canopy Growth (NAS:CGC) 5-Year RORE %

: -5.50% (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Canopy Growth's 5-Year RORE % for the quarter that ended in Jun. 2023 was -5.50%.

The industry rank for Canopy Growth's 5-Year RORE % or its related term are showing as below:

CGC's 5-Year RORE % is ranked worse than
58.84% of 911 companies
in the Drug Manufacturers industry
Industry Median: 1.70 vs CGC: -5.50

Canopy Growth 5-Year RORE % Historical Data

The historical data trend for Canopy Growth's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Annual Data

Trend

Jul13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

5-Year RORE %

51.47

37.56

3.99

20.91

Canopy Growth Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
5-Year RORE %																34.46	27.98	26.48	20.91	-5.50

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Canopy Growth 5-Year RORE % Distribution

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Canopy Growth's 5-Year RORE % falls in comparison to its industry or sector. The grey bar indicates the 5-Year RORE %'s extreme value range as defined by GuruFocus.

Canopy Growth 5-Year RORE % Calculation

Canopy Growth's 5-Year RORE % for the quarter that ended in Jun. 2023 is calculated as:

5-Year RORE %	=	( Most Recent EPS (Diluted)	-	First Period EPS (Diluted) )	/	( Cumulative EPS (Diluted) for 5-year	-	Cumulative Dividends per Share for 5-year )
	=	( -1.737	-	-2.588 )	/	( -15.478	-	0 )
	=	0.851	/	-15.478
	=	-5.50 %

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2023 and 5-year before.

Canopy Growth (NAS:CGC) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

Canopy Growth 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Canopy Growth's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth (NAS:CGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (NAS:CGC) » Definitions » 5-Year RORE %

Comparable Companies

Traded in Other Exchanges

11L1:Germany 11L1:Germany 11L1:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

Christelle Gedeon	officer: See Remarks	3 HOLLYHOCK COURT, TORONTO Z4 M3B 0B4
Garth Hankinson	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Hong Judy Eun Joo	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS Z4 K7A 0A8
Greenstar Ii Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Ii Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Grant Julious C. Jr	officer: Chief Commercial Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Sabia James A. Jr.	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Greenstar Canada Investment Limited Partnership	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9
Constellation Brands Canada Holdings Ulc	10 percent owner	QUEEN'S MARQUE, 600-1741 LOWER WATER STREET, HALIFAX A5 B3J 0J2
Theresa Yanofsky	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Thomas Carlton Stewart	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Tomas Iv Shipley	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Cbg Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Constellation Capital Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Canada Investment Corp	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9